Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review
- PMID: 24069006
- PMCID: PMC3779867
- DOI: 10.3389/fpsyt.2013.00115
Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review
Abstract
Recent reviews and meta-analyses suggest that reducing the duration of untreated psychosis leads to better symptomatic and functional outcome in patients with psychotic disorder. Early intervention attenuates the symptoms of individuals at clinical high-risk (HR) for psychosis and may delay or prevent their transition to psychosis. Identifying biological markers in the early stages of psychotic disorder is an important step toward elucidating the pathophysiology, improving prediction of the transition to psychosis, and introducing targeted early intervention for help-seeking individuals aiming for better outcome. Mismatch negativity (MMN) is a component of event-related potentials that reflects preattentive auditory sensory memory and is a promising biomarker candidate for schizophrenia. Reduced MMN amplitude is a robust finding in patients with chronic schizophrenia. Recent reports have shown that people in the early stages of psychotic disorder exhibit attenuation of MMN amplitude. MMN in response to duration deviants and in response to frequency deviants reveals different patterns of deficits. These findings suggest that MMN may be useful for identifying clinical stages of psychosis and for predicting the risk of development. MMN may also be a "translatable" biomarker since it reflects N-methyl-d-aspartte receptor function, which plays a fundamental role in schizophrenia pathophysiology. Furthermore, MMN-like responses can be recorded in animals such as mice and rats. This article reviews MMN studies conducted on individuals with HR for psychosis, first-episode psychosis, recent-onset psychosis, and on animals. Based on the findings, the authors discuss the potential of MMN as a clinical biomarker for early intervention for help-seeking individuals in the early stages of psychotic disorder, and as a translatable neurophysiological marker for the preclinical assessment of pharmacological agents used in animal models that mimic early stages of the disorder.
Keywords: animal; early intervention; first-episode psychosis; high-risk for psychosis; mismatch negativity; schizophrenia; translatable.
Figures
Similar articles
-
Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.Schizophr Res. 2017 Dec;190:32-38. doi: 10.1016/j.schres.2017.03.015. Epub 2017 Mar 15. Schizophr Res. 2017. PMID: 28314681
-
Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.Schizophr Res. 2013 Nov;150(2-3):547-54. doi: 10.1016/j.schres.2013.08.005. Epub 2013 Sep 6. Schizophr Res. 2013. PMID: 24012461
-
Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.Biol Psychiatry. 2014 Mar 15;75(6):459-69. doi: 10.1016/j.biopsych.2013.07.038. Epub 2013 Sep 16. Biol Psychiatry. 2014. PMID: 24050720 Free PMC article.
-
Mismatch negativity (MMN) as biomarker predicting psychosis in clinically at-risk individuals.Biol Psychol. 2016 Apr;116:36-40. doi: 10.1016/j.biopsycho.2015.10.010. Epub 2015 Nov 2. Biol Psychol. 2016. PMID: 26542526 Review.
-
Mismatch negativity (MMN) deficiency: a break-through biomarker in predicting psychosis onset.Int J Psychophysiol. 2015 Mar;95(3):338-44. doi: 10.1016/j.ijpsycho.2014.12.012. Epub 2015 Jan 3. Int J Psychophysiol. 2015. PMID: 25562834 Review.
Cited by
-
The effect of schizophrenia risk factors on mismatch responses in a rat model.Psychophysiology. 2023 Feb;60(2):e14175. doi: 10.1111/psyp.14175. Epub 2022 Sep 10. Psychophysiology. 2023. PMID: 36087044 Free PMC article.
-
Progressive Impairment of Mismatch Negativity Is Reflective of Underlying Pathophysiological Changes in Patients With First-Episode Psychosis.Front Psychiatry. 2020 Jun 18;11:587. doi: 10.3389/fpsyt.2020.00587. eCollection 2020. Front Psychiatry. 2020. PMID: 32625126 Free PMC article.
-
Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis.Front Psychiatry. 2020 Aug 3;11:770. doi: 10.3389/fpsyt.2020.00770. eCollection 2020. Front Psychiatry. 2020. PMID: 32848939 Free PMC article.
-
Autism and psychosis as diametrical disorders of embodiment.Evol Med Public Health. 2019 Jul 15;2019(1):121-138. doi: 10.1093/emph/eoz021. eCollection 2019. Evol Med Public Health. 2019. PMID: 31402979 Free PMC article.
-
Contributions of experimental psychiatry to research on the psychosis prodrome.Front Psychiatry. 2013 Dec 17;4:170. doi: 10.3389/fpsyt.2013.00170. Front Psychiatry. 2013. PMID: 24381564 Free PMC article. Review.
References
-
- McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry (2002) 59:921–810.1001/archpsyc.59.10.921 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources